Compression and CO2 Laser for Leg Wounds
Launched by NORTHWESTERN UNIVERSITY · Dec 12, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:Patients will be identified through the clinic where their skin is to be treated by excisional surgery on the lower leg. Those considered for enrollment must also meet the following criteria:
- • 1. \>18 years of age
- • 2. Wound size of at least 1 cm in width
- • 3. Cutaneous excision of the lower leg
- • 4. Surgeon elected repair of healing by secondary intention
- • 5. Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study
- Exclusion Criteria:
- • 1. Current smoker
- • 2. Uncontrolled diabetes mellitus
- • 3. Uncontrolled hypothyroidism
- • 4. Severe renal impairment or hypoalbuminemia
- • 5. Chronic lymphedema
- • 6. Severe venous insufficiency (large varicose veins, atrophie blanche)
- • 7. Arterial insufficiency (ABI \< 0.8)
- • 8. Rubber or rubber accelerator allergy
- • 9. Prior radiation to the surgical site
- • 10. History or evidence of a clinically significant medical or psychiatric disorder, condition or disease that in the opinion of the treating physician would pose a risk or interfere with evaluation or completion of the study
- • 11. Subject un willing to sign an IRB approved consent form
- • 12. Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Murad Alam, MD
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials